Rottapharm Biotech
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers (NCT05205330) | Rottapharm Biotech | 2021-11-23 |
| Intra-articular PVA Hydrogel in Knee Osteoarthritis (NCT04693104) | Rottapharm Biotech | 2019-10-01 |
| A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis (NCT03163966) | Rottapharm Biotech | 2017-10-05 |
Track Rottapharm Biotech automatically
Every clearance here is in the API, with alerts when new ones post.